June 2020 Issue

GO TO FULL ISSUE


Need CE? Access a library of 300+ pharmacist CE courses with a subscription to Pharmacist's Letter Canada

MED UPDATES

Rybelsus
semaglutide
New oral formulation GLP-1 agonist for type 2 diabetes

Mayzent
siponimod
An oral sphingosine 1-phosphate receptor modulator for multiple sclerosis

Vascepa
icosapent ethyl
An oral omega-3 fatty acid to decrease triglycerides

MORE MED UPDATES